Human menopausal gonadotrophins


Concise Prescribing Info
Indications/Uses
Listed in Doasge.
Dosage/Direction for Use
Adult : IM/SC Female infertility 75-150 u/day of FSH, adjust slowly until adequate response. Stop treatment and follow after 1-2 days by single dose of chorionic gonadotrophin 5,000-10,000 u. In menstruating patients, start w/in the 1st 7 days of menstrual cycle. Stop treatment if no response is seen in 3 wk. May repeat course twice more, if needed. Male infertility 75 or 150 u of FSH 2-3 times/wk for at least 3 or 4 mth. In vitro fertilisation procedures or other assisted conception techniques W/ chorionic gonadotrophin and sometimes clomiphene citrate or a gonadorelin analogue: 75-300 u/day of FSH, beginning on day 2 or 3 of menstrual cycle. Combined regimen: W/ clomiphene citrate on days 2-6 of menstrual cycle, start on day 5 w/ 150-225 u/day of FSH; continue until adequate response, followed by up to 10,000 u of chorionic gonadotrophin 1-2 days after the final inj.
Dosage Details
Parenteral
Female infertility
Adult: 75-150 units of FSH daily via IM or SC inj; adjust gradually until adequate response is achieved. Treatment is stopped and followed after 1 or 2 days by single dose of chorionic gonadotrophin 5000-10,000 units. In menstruating patients, start within the 1st 7 days of menstrual cycle. Alternatively, 3 equal doses IM or SC, each providing 225-375 units of FSH on alternate days followed by chorionic gonadotrophin 1 wk after the 1st dose. Stop treatment if no response is seen in 3 wk. Course may be repeated twice more, if necessary.

Parenteral
Male infertility
Adult: Stimulate spermatogenesis with chorionic gonadotrophin, then with human menopausal gonadotrophin in a dose of 75 or 150 units of FSH 2 or 3 times wkly by IM or SC. Treatment should be continued for at least 3 or 4 mth.

Parenteral
In vitro fertilisation procedures or other assisted conception techniques
Adult: (In conjunction with chorionic gonadotrophin and sometimes clomiphene citrate or a gonadorelin analogue.) 75-300 units of FSH daily via IM or SC inj usually beginning on the 2nd or 3rd day of menstrual cycle. Combined regimen: 100 mg clomiphene citrate on days 2-6, with human menopausal gonadotrophins beginning on day 5 in a dose providing 150-225 units of FSH daily. Continue until an adequate response is obtained; final inj of human menopausal gonadotrophins is followed 1-2 days later with up to 10,000 units of chorionic gonadotrophin.
Contraindications
Ovarian cysts or enlargement not caused by polycystic ovarian syndrome; tumors of breast, uterus, ovaries, testes or prostate; vaginal bleeding of unknown cause; pregnancy and lactation.
Special Precautions
Hyperprolactinemia or tumors of the pituitary or hypothalamus. Ovarian enlargement at risk of rupture, care in pelvic examinations. Risk of multiple births.
Adverse Reactions
Ovarian hyperstimulation, risk of multiple pregnancy and miscarriage, hypersensitivity and local reactions at Inj site, nausea, vomiting, joint pain, fever. In men, gynecomastia, acne, weight gain.
Potentially Fatal: Rupture of ovarian cysts and intraperitoneal haemorrhage.
IM/Parenteral/SC: X
Drug Interactions
Drugs with luteinising hormone activity may increase risk of ovarian hyperstimulation syndrome.
Action
Description: Human menopausal gonadotrophins possess both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activities.
Disclaimer: This information is independently developed by MIMS based on Human menopausal gonadotrophins from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in